HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete response to alemtuzumab in a patient with B prolymphocytic leukemia.

AuthorsBassem T Chaar, Paul J Petruska
JournalAmerican journal of hematology (Am J Hematol) Vol. 82 Issue 5 Pg. 417 (May 2007) ISSN: 0361-8609 [Print] United States
PMID17160995 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab
Topics
  • Alemtuzumab
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • B-Lymphocytes (pathology)
  • Combined Modality Therapy
  • Humans
  • Leukemia, Prolymphocytic (drug therapy, pathology, surgery)
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation
  • Remission Induction
  • Transplantation, Autologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: